{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:19:12Z","timestamp":1783487952601,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.4158\/ep-2020-0405","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T12:33:12Z","timestamp":1601037192000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Echocardiographic Findings in Patients With Normocalcemic Primary\u00a0Hyperparathyroidism Compared With Findings in\u00a0Hypercalcemic Primary Hyperparathyroid Patients and Control\u00a0Subjects"],"prefix":"10.1016","volume":"27","author":[{"given":"Jessica","family":"Pepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Occhiuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"del Fattore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Santori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Mastrantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sgreccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.4158\/EP-2020-0405_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.4158\/EP-2020-0405_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000491036","article-title":"Normocalcemic hyperparathyroidism","volume":"51","author":"Corbetta","year":"2019","journal-title":"Front Horm Res"},{"issue":"1","key":"10.4158\/EP-2020-0405_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schl\u00fcter","year":"1998","journal-title":"Cardiovasc Res"},{"issue":"22","key":"10.4158\/EP-2020-0405_bib4","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"Saleh","year":"2003","journal-title":"Eur Heart J"},{"issue":"6","key":"10.4158\/EP-2020-0405_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.beem.2018.06.006","article-title":"Non classical complications of primary hyperparathyroidism","volume":"32","author":"Chiodini","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"10.4158\/EP-2020-0405_bib6","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.4158\/EP-2020-0405_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.4158\/EP-2020-0405_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna","year":"2016","journal-title":"J\u00a0Bone Miner Metab"},{"issue":"2","key":"10.4158\/EP-2020-0405_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ15-0392","article-title":"Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients","volume":"63","author":"Ozturk","year":"2016","journal-title":"Endocr J"},{"issue":"6","key":"10.4158\/EP-2020-0405_bib10","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2014-4432","article-title":"Is normocalcemic primary hyperparathyroidism harmful or harmless?","volume":"100","author":"Chen","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.4158\/EP-2020-0405_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.4158\/EP-2020-0405_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cca.2018.03.028","article-title":"Circulating parathyroid hormone and risk of hypertension: a meta-analysis","volume":"482","author":"Zhang","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.4158\/EP-2020-0405_bib13","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2015-3202","article-title":"Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis","volume":"100","author":"McMahon","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"43","key":"10.4158\/EP-2020-0405_bib14","doi-asserted-by":"crossref","first-page":"e7255","DOI":"10.1097\/MD.0000000000007255","article-title":"Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: a\u00a0systematic review and meta-analysis","volume":"96","author":"Best","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.4158\/EP-2020-0405_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302010000200004","article-title":"Normocalcemic primary hyperparathyroidism","volume":"54","author":"Bilezikian","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.4158\/EP-2020-0405_bib16","doi-asserted-by":"crossref","first-page":"h2723","DOI":"10.1136\/bmj.h2723","article-title":"The diagnosis and management of hypercalcaemia","volume":"350","author":"Minisola","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.4158\/EP-2020-0405_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.ejcn.1601278","article-title":"Validation of a food frequency questionnaire for nutritional calcium intake assessment in Italian women","volume":"56","author":"Montomoli","year":"2002","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.4158\/EP-2020-0405_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-13-0293","article-title":"Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test","volume":"169","author":"Pepe","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.4158\/EP-2020-0405_bib19","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/clinchem\/47.7.1314","article-title":"Biomarkers of bone turnover after a\u00a0short period of steroid therapy in elderly men","volume":"47","author":"Paglia","year":"2001","journal-title":"Clin Chem"},{"issue":"5","key":"10.4158\/EP-2020-0405_bib20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2265.2012.04452.x","article-title":"The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture","volume":"77","author":"Pepe","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.4158\/EP-2020-0405_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/eci.12038","article-title":"Arrhythmias in primary hyperparathyroidism evaluated by exercise test","volume":"43","author":"Pepe","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"10.4158\/EP-2020-0405_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2019.02.027","volume":"74","author":"Douglas","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.4158\/EP-2020-0405_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1530\/EJE-15-1152","article-title":"High prevalence of abdominal aortic calcification in patients with primary hyperparathyroidism as evaluated by Kauppila score","volume":"175","author":"Pepe","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.4158\/EP-2020-0405_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/cen.14064","article-title":"Investigating subtle kidney injury in primary hyperparathyroidism by means of sensitive and specific biomarkers","volume":"91","author":"Cipriani","year":"2019","journal-title":"Clin Endocrinol.(Oxf)"},{"issue":"5","key":"10.4158\/EP-2020-0405_bib25","first-page":"1815","article-title":"Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism","volume":"85","author":"Barletta","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.4158\/EP-2020-0405_bib26","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.4158\/EP-2020-0405_bib27","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/ERP-19-0050","article-title":"Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice: a guideline from the British Society of Echocardiography","volume":"7","author":"Harkness","year":"2020","journal-title":"Echo Res Pract"},{"issue":"1","key":"10.4158\/EP-2020-0405_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02173","article-title":"Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening","volume":"155","author":"Hagstr\u00f6m","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.4158\/EP-2020-0405_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s12020-014-0263-5","article-title":"Investigation of glucose intolerance in patients with normocalcemic primary hyperparathyroidism: 4-year follow-up","volume":"47","author":"Diri","year":"2014","journal-title":"Endocrine"},{"issue":"11","key":"10.4158\/EP-2020-0405_bib30","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40618-018-0879-z","article-title":"Clinical presentation and management of patients with primary hyperparathyroidism in Italy","volume":"41","author":"Saponaro","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"7","key":"10.4158\/EP-2020-0405_bib31","doi-asserted-by":"crossref","first-page":"dgaa174","DOI":"10.1210\/clinem\/dgaa174","article-title":"Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism","volume":"105","author":"Palermo","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7 Suppl","key":"10.4158\/EP-2020-0405_bib32","first-page":"40","article-title":"Sporadic and hereditary primary hyperparathyroidism","volume":"34","author":"Pepe","year":"2011","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.4158\/EP-2020-0405_bib33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00198-014-3000-2","article-title":"Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism","volume":"26","author":"Cesareo","year":"2015","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.4158\/EP-2020-0405_bib34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S2213-8587(16)00076-0","article-title":"Explaining geographical variation in the presentation of primary hyperparathyroidism","volume":"4","author":"Minisola","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20483223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:21Z","timestamp":1761516441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20483223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1530891X20483223"],"URL":"https:\/\/doi.org\/10.4158\/ep-2020-0405","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Echocardiographic Findings in Patients With Normocalcemic Primary\u00a0Hyperparathyroidism Compared With Findings in\u00a0Hypercalcemic Primary Hyperparathyroid Patients and Control\u00a0Subjects","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2020-0405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}